ACHE and Alzheimer disease: Interestingly enough Appleyard and Macdonald [10] have demonstrated a selective reduction only in the soluble i.e. releasable form of AChE from the adrenal gland in AD, perhaps due to its enhanced secretion into the plasma, where it is elevated in AD patients [11], [12].